While several trials have shown that substantial weight loss using diet and lifestyle can reverse type 2 diabetes, new research published in Diabetologia is among the first to show the subsequent impact of remission on cardiovascular ...
Jan 18, 2024
0
1
Symptom burden during repetitive transcranial magnetic stimulation (rTMS) treatment for major depressive disorder (MDD) may be most accurately assessed through the use of multiple instruments, according to a study published ...
Dec 29, 2023
0
15
A study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into ...
Dec 10, 2023
0
15
Patients with inflammatory bowel disease (IBD) and high visceral adipose tissue (VAT) may have more difficulty achieving higher infliximab levels necessary to achieve remission, according to a study published in the November ...
Nov 15, 2023
0
0
Researchers from the Germans Trias i Pujol Research Institute (IGTP) have led a comprehensive review study on biomarkers for the often-overlooked partial remission phase of type 1 diabetes in collaboration with experts in ...
Nov 14, 2023
0
5
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, has found that rheumatoid arthritis (RA) patients in sustained remission who stopped TNF inhibitors (TNFi) had significantly ...
Nov 10, 2023
0
1
Peanut sublingual immunotherapy (SLIT) is safe and effective at inducing desensitization and remission in 1- to 4-year-old children, according to a study published online Oct. 10 in the Journal of Allergy and Clinical Immunology.
Nov 5, 2023
0
20
For patients with inflammatory bowel disease (IBD), monitoring by intestinal ultrasound (IUS) results in reduced time to treatment change and to remission, according to a study presented at the annual meeting of the American ...
Oct 25, 2023
0
2
The U.S. Food and Drug Administration has approved Velsipity (etrasimod) for adults with moderately to severely active ulcerative colitis (UC).
Oct 18, 2023
0
0
For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficacious for achieving ...
Oct 5, 2023
0
1
